Home / Japan / Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc.
Short position disclosed on August 18, 2026.
1.24% of the capital sold short
1 disclosing funds
1 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Aug 19
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| 大和証券株式会社 | 1.24% | unchanged | August 18, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 18, 2026 | 大和証券株式会社 | 1.24% | still open |
Other companies sold short in Japan
- Unitika LTD. 13.56% of the capital sold short
- eole Inc. 13.32% of the capital sold short
- Oncolys BioPharma Inc. 11.95% of the capital sold short
- Jibannet Holdings Co.,Ltd. 10.62% of the capital sold short
- Terra Drone Corporation 10.36% of the capital sold short
- Renascience Inc. 9.88% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.09% of the capital sold short
- Fixstars Corporation 8.75% of the capital sold short
- AKIBA Holdings Co.,Ltd. 8.34% of the capital sold short
- TESS Holdings Co.,Ltd. 8.07% of the capital sold short
- Towa Corporation 7.87% of the capital sold short
- ExaWizards Inc. 7.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Noile-Immune Biotech Inc., source JPX, data as at August 18, 2026, https://www.quivad.com/action/noile-immune-biotech-inc